Year |
Citation |
Score |
2013 |
Jube SL, Rivera Z, Casalgrandi M, Bianchi M, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 5557: BoxA and ethyl pyruvate offer novel therapeutic approaches for human malignant mesothelioma. Cancer Research. 73: 5557-5557. DOI: 10.1158/1538-7445.Am2013-5557 |
0.595 |
|
2013 |
Croce A, Musa M, Allegrina M, Rinaudo C, Baris YI, Dogan AU, Powers A, Rivera Z, Bertino P, Yang H, Gaudino G, Carbone M. Micro-Raman spectroscopy identifies crocidolite and erionite fibers in tissue sections Journal of Raman Spectroscopy. 44: 1440-1445. DOI: 10.1002/Jrs.4286 |
0.475 |
|
2012 |
Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63. PMID 22893632 DOI: 10.1158/1078-0432.Ccr-12-0628 |
0.54 |
|
2012 |
Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301. PMID 22552293 DOI: 10.1158/0008-5472.Can-11-3481 |
0.577 |
|
2012 |
Jube S, Rivera Z, Bianchi M, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 1557: High mobility group box 1 secretion supports tumor progression of human malignant mesothelioma Cancer Research. 72: 1557-1557. DOI: 10.1158/1538-7445.Am2012-1557 |
0.585 |
|
2011 |
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5. PMID 21874000 DOI: 10.1038/Ng.912 |
0.563 |
|
2011 |
Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. 108: 13618-23. PMID 21788493 DOI: 10.1073/Pnas.1105887108 |
0.594 |
|
2011 |
Jube S, Rivera Z, Gaudino G, Pass HI, Bianchi ME, Carbone M, Yang H. Abstract 2600: HMGB1, a potential new target for mesothelioma therapy Cancer Research. 71: 2600-2600. DOI: 10.1158/1538-7445.Am2011-2600 |
0.586 |
|
2010 |
Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/Pnas.1006542107 |
0.601 |
|
2009 |
Yang H, Nasu M, Strianese O, Rivera Z, Luecke L, Carbone M. The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20. PMID 19365925 |
0.552 |
|
2008 |
Rivera Z, Strianese O, Bertino P, Yang H, Pass H, Carbone M. The relationship between simian virus 40 and mesothelioma. Current Opinion in Pulmonary Medicine. 14: 316-21. PMID 18520265 DOI: 10.1097/Mcp.0B013E3283018220 |
0.49 |
|
Show low-probability matches. |